DUSTY SCOTT: Open Payments
NPI 1043306012 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 78 payments from 20 companies in 2025. Trend: 2023 $1,485 · 2024 $1,582 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 23 | $252 |
| Novartis Pharmaceuticals Corporation | 15 | $210 |
| Merck Sharp & Dohme LLC | 10 | $159 |
| BridgeBio Pharma, Inc. | 3 | $69 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| SCPHARMACEUTICALS INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| AngioDynamics, Inc. | 1 | $35 |
Products named: CAMZYOS, LEQVIO, VERQUVO, ELIQUIS, Attruby, JARDIANCE, FUROSCIX, Wegovy.
Industry payments across NC — which companies pay providers there.
